Communication NPSG Data.pdf
\nNational Patient Safety Goal Data: Communication<\/p>\n
NPSG 2: Improving Effectiveness of Communication\u2014 Critical Results<\/p>\n
63 58<\/p>\n
62<\/p>\n
75 68<\/p>\n
56 57<\/p>\n
82<\/p>\n
77 78 82 80<\/p>\n
0<\/p>\n
25<\/p>\n
50<\/p>\n
75<\/p>\n
100<\/p>\n
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec<\/p>\n
Hospital-Wide Compliance of Reporting Critical Results within 60 Minutes as Evidenced by Documentation<\/p>\n
January\u2013December<\/p>\n
NPSG 2: Improving Effectiveness of Communication\u2014 Verbal Orders\/Read-Backs<\/p>\n
97 97<\/p>\n
62<\/p>\n
96 91<\/p>\n
100 98 99<\/p>\n
0<\/p>\n
25<\/p>\n
50<\/p>\n
75<\/p>\n
100<\/p>\n
%<\/p>\n
CC U<\/p>\n
Te le<\/p>\n
O rt ho<\/p>\n
M ed<\/p>\n
ic al U<\/p>\n
ni t<\/p>\n
Su rg<\/p>\n
ic al U<\/p>\n
ni t<\/p>\n
ED<\/p>\n
En do<\/p>\n
sc op<\/p>\n
y<\/p>\n
PA CU<\/p>\n
Verbal Order\/Read Back Audits<\/p>\n
Fiscal Year to Date<\/p>\n
NPSG 2: Improving Effectiveness of Communication\u2014 Unacceptable Abbreviations<\/p>\n
99.6%<\/p>\n
Universal Protocol<\/p>\n
Communication Preprocecure Handoff.pdf
\nPreprocedure Hand-Off<\/p>\n
Y N<\/p>\n
Identification \/ allergy armband on patient’s arm?<\/p>\n
Do Not Resuscitate (DNR) status: ___________________________________________________<\/p>\n
Allergies :<\/p>\n
Latex allergy?<\/p>\n
Isolation Status?<\/p>\n
Patient seen by Anesthesia?<\/p>\n
Consent form signed?<\/p>\n
History & physical on chart?<\/p>\n
Lab, chest x-ray, electrocardiogram on chart if ordered?<\/p>\n
Medication Administration Record (MAR) \/ transfer medication form on chart?<\/p>\n
Type and screen completed?<\/p>\n
Units of blood ordered?<\/p>\n
Transport sheet prepared?<\/p>\n
Intravenous sites \/ tubing labeled?<\/p>\n
Preop medications given and time? __________________________________________________<\/p>\n
Preop antibiotic administered to patient on unit @ what time?_______________________________<\/p>\n
Preop antibiotic sent to OR with patient?_______________________________________________<\/p>\n
Dentures removed?<\/p>\n
Glasses \/ contacts removed?<\/p>\n
Hearing aid removed?<\/p>\n
Metal implants? If yes, where?<\/p>\n
Jewelry removed or Patient refused to sign “Jewelry Removal” form to be placed on chart?<\/p>\n
Clothing \/ underwear removed?<\/p>\n
Primary language is English. If no, primary language is ______________________________________<\/p>\n
Patient’s contact person \/information?<\/p>\n
“NPO” (since ________________)<\/p>\n
Voided? (@ _________________)<\/p>\n
Operative site marked?<\/p>\n
Time: Last Vital Signs: Temperature? Blood Pressure?<\/p>\n
Respirations? Pulse?<\/p>\n
Messages to Operating Room ?________________________________________________________<\/p>\n
Nurse HANDING OFF patient : ____________________________Date: _________ Time: _______<\/p>\n
Nurse ACCEPTING patient: ____________________________Date: _________ Time: _______<\/p>\n
Communication Site Identification Policy.pdf
\nSite Identification and Verification (Universal Protocol)<\/p>\n
Policy<\/p>\n
Wrong-site, wrong-procedure, and wrong-person surgery can be prevented. This universal protocol is intended to achieve that goal. It is based on the consensus of experts from the relevant clinical specialties and professional disciplines and endorsed by hospital administration.<\/p>\n
In developing this protocol, consensus was reached on the following principles:<\/p>\n
Wrong-site, wrong-procedure, wrong-person surgery can and must be prevented.<\/p>\n
A robust approach\u2014using multiple, complementary strategies\u2014is necessary to achieve the goal of eliminating wrong-site, wrong -procedure, wrong-person surgery.<\/p>\n
Active involvement and effective communication among all members of the patient care team is important for success.<\/p>\n
To the extent possible, the patient (or legally designated representative) should be involved in the process.<\/p>\n
Consistent implementation of a standardized approach using a universal, consensus-based protocol will be most effective.<\/p>\n
The protocol should be flexible enough to allow for implementation with appropriate adaptation when required to meet specific patient needs.<\/p>\n
A requirement for site marking should focus on cases involving right\/left distinction, multiple structures (fingers, toes), or levels (spine).<\/p>\n
The policy\/procedure should be applicable or adaptable to all operative and other invasive procedures that expose patients to harm, including procedures done in settings other than the operating room.<\/p>\n
Preoperative\/Preprocedure Verification Process<\/p>\n
Verification of the correct person, procedure, and site will occur (as applicable):<\/p>\n
1. At the time of admission\/entry to the facility 2. Anytime the responsibility for care of the patient is transferred to another caregiver 3. With the patient awake and aware, if possible 4. Before the patient leaves the preoperative\/preprocedural area 5. Immediately prior to beginning the operative\/invasive procedure<\/p>\n
Marking the Operative\/Invasive Site:<\/p>\n
1. All patients undergoing operative or invasive procedures will identify and mark the operative\/invasive site prior to the procedure when applicable. 2. Site marking should be done for any procedure that involves laterality, multiple structures, or levels. 3. The mark should be made with a permanent marker that will remain visible after skin prep. 4. X-ray may be used as reference for identifying levels of the spine. 5. Needle localization may be used as reference for identifying breast lesions. 6. In the event any patient refuses to mark the operative\/invasive procedure site, the physician will be notified. 7. Sites\/procedures exempt from marking include the following:<\/p>\n
Page 2<\/p>\n
Endoscopic procedures<\/p>\n
Nasal procedures<\/p>\n
Rectal procedures<\/p>\n
Cystoscopies<\/p>\n
Perineal surgery<\/p>\n
T&A’s and M&T’s<\/p>\n
Single organ cases (e.g., cesarean section, cardiac surgery)<\/p>\n
Abdominal surgery when site is not specified<\/p>\n
Interventional sites where insertion site is not determined (e.g., cardiac catheterization, catheter placement)<\/p>\n
8. Justification for not marking the site must be documented in the preoperation checklist. 9. If the patient\/guardian is unable to mark the site or if there is any confusion concerning the appropriate site\/sites, the physician will be notified to identify and mark the site. 10. Patients undergoing procedures that will require sedation or anesthesia will not be transported to the operative suite\/procedural room until the site is marked as indicated. 11. Straight local procedures, using no sedation\/anesthesia may be taken to OR\/Minor Room and marked by the physician. 12. Laterality will be marked by writing RT for right, LT for left or BIL for bilateral as appropriate. 13. Place a “” on visible or palpable lesions (e.g., lipoma, mass, mole) Exception: Breast lesions\/masses will be identified by the surgeon. 14. Spines will be marked by writing “C” (cervical), “T” (thoracic), “L” (lumbar), “S” (sacral) in the area of the back representing location and on the side of the spine the patient identifies as having greater pain. Radiographic films may be used intra-operatively to identify precise levels. 15. Teeth do not require marking, however, dental radiographs or diagrams must be marked and available at the time of the procedure.<\/p>\n
Patient, Procedure, and Site Verification<\/p>\n
Preprocedurally or preoperatively, the nurse providing care to the patient will complete the following:<\/p>\n
1. Verify the operative\/invasive procedure and site with the patient\/guardian 2. Verify the order for the informed consent with the actual informed consent document. If discrepancy exists, notify the physician. 3. If no discrepancies exist between the informed consent and the physician’s order indicating the procedure to be performed, provide the patient\/guardian with a permanent black marker and instruct him or her in the following:<\/p>\n
When side (right, left, bilateral) is indicated, mark RT (right), LT (left) or BIL (bilateral) to indicate the correct side on which the procedure is being performed.<\/p>\n
When a mass or lesion is being removed, place a check mark ( \uf0fc ) on the mass\/lesion to identify the appropriate site(s). Exception: Breast lesions\/masses will be identified by the surgeon<\/p>\n
Care should be taken not to obscure visualization of the lesion.<\/p>\n
Markings should be visible once the patient is prepped and draped.<\/p>\n
Time-Out Procedure<\/p>\n
Immediately prior to beginning the procedure, the nurse or technologist is responsible for calling the time-out. All members of the team have the responsibility to ensure a time-out is called prior to beginning the procedure. The duration and participants of the time-out are documented in the record.<\/p>\n
1. The patient\u2019s chart will be used as a reference when calling the time-out. 2. At this time, all personnel involved in the procedure audibly and verbally agree on the following:<\/p>\n
Correct patient identity<\/p>\n
Page 3<\/p>\n
Correct side and site<\/p>\n
Correct procedure to be done<\/p>\n
Correct patient position<\/p>\n
Availability of correct implants and any special equipment<\/p>\n
Any and all members of the team may request clarification of the correct side or site at any time.<\/p>\n
3. In the case of any discrepancies between the consent, medical records, x-rays, imaging studies, pathology reports or any discrepancies between the patient, the patient’s representative, or members of the team, all activities will be halted immediately until verifications can be completed. 4. Patients who are awake during the time-out process should be active participants.<\/p>\n
Bedside Procedures<\/p>\n
The above policy and procedure must be followed for any procedure that involves laterality, multiple structures, or levels. The site marking is not required if the individual performing the procedure is in continuous attendance with the patient from the time of decision and consent from the patient through to the beginning of the procedure.<\/p>\n
Approved by Surgery Leadership Committee<\/p>\n
Infection Control Data.pdf
\nInfection Control Data<\/p>\n
Multidrug-Resistant Organisms<\/p>\n
0<\/p>\n
0.5<\/p>\n
1<\/p>\n
1.5<\/p>\n
2<\/p>\n
2.5<\/p>\n
3<\/p>\n
3.5<\/p>\n
4<\/p>\n
4.5<\/p>\n
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec<\/p>\n
# o<\/p>\n
f In<\/p>\n
fe c ti<\/p>\n
o n<\/p>\n
s<\/p>\n
0<\/p>\n
0.5<\/p>\n
1<\/p>\n
1.5<\/p>\n
2<\/p>\n
2.5<\/p>\n
3<\/p>\n
3.5<\/p>\n
4<\/p>\n
4.5<\/p>\n
5<\/p>\n
R a<\/p>\n
te \/1<\/p>\n
0 0 0<\/p>\n
p a<\/p>\n
ti e<\/p>\n
n t<\/p>\n
d a<\/p>\n
y s<\/p>\n
Rate # of MDRO Rolling Rate<\/p>\n
Central Line-Blood Stream Infection<\/p>\n
0<\/p>\n
1<\/p>\n
2<\/p>\n
3<\/p>\n
4<\/p>\n
5<\/p>\n
6<\/p>\n
7<\/p>\n
8<\/p>\n
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec<\/p>\n
# o<\/p>\n
f in<\/p>\n
fe c ti<\/p>\n
o n<\/p>\n
s<\/p>\n
R a te<\/p>\n
\/1 0 0 0 p<\/p>\n
a ti<\/p>\n
e n<\/p>\n
t d<\/p>\n
a y s<\/p>\n
Rate # of CL-BSI Rolling Rate<\/p>\n
Page 2<\/p>\n
93 92 92 92<\/p>\n
96 96<\/p>\n
91<\/p>\n
94<\/p>\n
80<\/p>\n
90<\/p>\n
100<\/p>\n
Hospital-Wide Nursing Ancillary Physician<\/p>\n
Hand Hygiene Observed Compliance<\/p>\n
Last Year<\/p>\n
Current YTD<\/p>\n
84 85<\/p>\n
97<\/p>\n
83<\/p>\n
87<\/p>\n
75<\/p>\n
80<\/p>\n
85<\/p>\n
90<\/p>\n
95<\/p>\n
100<\/p>\n
Q1 Q2 Q3 Q4 Year End<\/p>\n
Central Line Bundle Compliance (Compliance with Evidence-Based Care Standards)<\/p>\n
Page 3<\/p>\n
78 85 89<\/p>\n
95 88<\/p>\n
0<\/p>\n
20<\/p>\n
40<\/p>\n
60<\/p>\n
80<\/p>\n
100<\/p>\n
Q1 Q2 Q3 Q4 Year End<\/p>\n
MDRO Bundle Compliance (Compliance with Evidence-Based Care Standards)<\/p>\n
Infection Control Environmental Rounds Data.pdf
\nInfection Control: Environmental Rounds Data<\/p>\n
Infection Control Management<\/p>\n
All Depts Initial<\/p>\n
Rounds<\/p>\n
Clinical Depts Bi- Annual Rounds<\/p>\n
Previous Year 1<\/p>\n
Previous Year 2<\/p>\n
Previous Year 3<\/p>\n
General environment is dust-free including air vents. 79.2% 66.7% 73.0% 83.7% 84.1%<\/p>\n
Staff is compliant with food\/drink restrictions. 61.5% 53.8% 57.7% 84.6% 80.2%<\/p>\n
Refrigerators have appropriate items stored per guidelines (labeled, dated, not expired, etc.). 65.2% 75.0% 70.1% 81.8% 82.8%<\/p>\n
All refrigerator temperatures are checked daily. Refrigerators are clean. 79.2% 68.0% 73.6% 76.8% 79.1%<\/p>\n
Ice machine is clean. 71.4% 85.7% 78.6% 82.1% 89.0%<\/p>\n
Isolation cabinet is on door with appropriate sign and is stocked. 66.7% 80.0% 73.3% 62.5% 92.9%<\/p>\n
Negative pressure rooms are @ negative pressure (tissue test) and alarms are functioning at approved settings. 100.0% 100.0% 100.0% 100.0% 100.0%<\/p>\n
Patient rooms\/bathrooms are clean and free of dust, spills, and excessive trash; walls are clean and rooms are in good repair. 89.5% 80.0% 84.7% 82.5% 61.2%<\/p>\n
Clean linen is properly stored. 81.8% 86.4% 84.1% 88.6% 92.5%<\/p>\n
Alcohol foam\/gel is easily accessible and has not expired. 88.9% 85.2% 87.0% 98.1% 88.5%<\/p>\n
Hopper in dirty utility room does not have stagnant water (has been recently flushed). 90.0% 90.0% 90.0% 95.8% 90.0%<\/p>\n
Preparation areas\/carts are clean and free of any med ‘remnants’. 90.9% 91.3% 91.1% 97.6% 97.2%<\/p>\n
Multidose vials are within expiration date; insulin vials are dated. 89.5% 94.4% 92.0% 87.8% 78.0%<\/p>\n
Supplies are not expired (e.g.., hemocult, specimen containers\/tubes). 94.2% 88.9% 91.6% 91.1% 96.1%<\/p>\n
Staff members are compliant with hand hygiene guidelines. 95.7% 100.0% 97.8% 100.0% 100.0%<\/p>\n
BGM kits are clean and reagents are not expired. 94.1% 78.6% 86.3% 83.3% 78.6%<\/p>\n
Hospital-wide average 83.6% 82.7% 83.2% 88.1% 88.2%<\/p>\n
Infection Control SSI Data.pdf
\nInfection Control: SSI Data<\/p>\n
98 100<\/p>\n
99 100 100<\/p>\n
96 95<\/p>\n
97 98 98<\/p>\n
97 96<\/p>\n
75<\/p>\n
80<\/p>\n
85<\/p>\n
90<\/p>\n
95<\/p>\n
100<\/p>\n
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec<\/p>\n
Antibiotic Selection<\/p>\n
50<\/p>\n
100 100 100 100 100 97 99<\/p>\n
100 100 99 100<\/p>\n
50<\/p>\n
60<\/p>\n
70<\/p>\n
80<\/p>\n
90<\/p>\n
100<\/p>\n
Jan Feb M ar Apr M ay Jun Jul Aug Sep Oct Nov Dec<\/p>\n
Normathermia<\/p>\n
98 99 100 100 100 100 100 99 100 100 100 100<\/p>\n
50<\/p>\n
60<\/p>\n
70<\/p>\n
80<\/p>\n
90<\/p>\n
100<\/p>\n
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec<\/p>\n
Appropriate Hair Removal<\/p>\n
(Clipping)<\/p>\n
98 96 98<\/p>\n
87 94 95 94<\/p>\n
90 85<\/p>\n
92 91 94<\/p>\n
50<\/p>\n
60<\/p>\n
70<\/p>\n
80<\/p>\n
90<\/p>\n
100<\/p>\n
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec<\/p>\n
Recommended VTE Prophylaxis<\/p>\n
Ordered<\/p>\n
Infection Control SSI Focus Review.pdf
\nCONFIDENTIAL<\/p>\n
Executive Homework help – Summary of Surgical Site Infection Focus Review<\/p>\n
The following is the result of the Surgical Site Infection Focus Review from the Joint Commission.<\/p>\n
Excellent Patient Care<\/p>\n
Rates of surgical site infection (SSI) following colon surgery, abdominal hysterectomy, total hip replacement and spinal fusion were similar to or lower than the mean rates of SSI for similar procedures performed by comparable hospitals. We believe these encouraging data can be used to reinforce and improve on your infection surveillance and prevention efforts.<\/p>\n
Areas to Monitor<\/p>\n
The rate of SSI following total knee replacement was higher than the mean rate of SSI following similar procedures at comparable hospitals. The difference, however, did not reach statistical significance. We will continue to monitor rates of SSI following these procedures.<\/p>\n
In particular, we recommend implementing a system to ensure that appropriate perioperative antimicrobial agents are provided within one hour of incision. In addition, weight-based dosing in obese patients and redosing of antibiotics for prolonged procedures may help reduce rates of SSI. If these high rates continue despite strict adherence with these recommendations, we will assist you in performing a more detailed analysis of the issue.<\/p>\n
Areas for Improvement<\/p>\n
The rate of SSI in general surgery procedures was statistically higher than the mean rate of SSI following general surgery at comparable hospitals (p=0.0001).<\/p>\n
Given this statistically significant difference, we performed additional analyses after stratifying the rate of SSI by the NNIS risk index. The most notable difference was found among patients at highest risk for SSI (NNIS risk index of 2 or greater). While case-mix may have contributed to the overall increase in the rate of SSI following general surgery, highest risk patients had an almost two-times higher rate of SSI following general surgery at Nightingale Memorial Hospital compared to highest risk patients undergoing general surgery at comparable hospitals (4.96\/100 procedures vs. 1.79\/100 procedures; p=0.01).<\/p>\n
Thus, we recommend strict adherence to appropriate antimicrobial prophylaxis, including administering an appropriate agent within one hour prior to incision. In addition, you may consider administering an additional dose if the procedure is greater than 3 hours in length. Finally, we recommend weight-adjusting doses of antibiotics for obese patients.<\/p>\n
Infection Control SSI Patient Education.pdf
\nInfection Control Surveillance Objectives.pdf
\nInfection Control: Surveillance Objectives<\/p>\n
Date: April 23 rd<\/p>\n
After reviewing the previous fiscal year data and performing the infection control risk assessment for the hospital, the following will be the surveillance objectives for the coming year:<\/p>\n
1. Primary Bloodstream Infections: House-wide surveillance for 12 months. With implementation of infection reduction strategies including six-sigma project, reporting central line infections per 1000 patient days and 1000 central line days house wide, implementing CHG bathing in ICU. Goal: Reduce the CL-BSI rate to < 0.1\/1000 patient days by the end of the year<\/p>\n
2. ICU Nosocomial Infections: All device-related nosocomial infections for 12 months including central line and ventilator bundle compliance. Goal: \u201cZero\u201d for CL-BSI and VAP infections and <1.0 FR-UTI\/1000 Foley Days.<\/p>\n
3. Nosocomial transmission of Multidrug-Resistant Organisms: MRSA\/VRE\/ESBL\/KPC infection surveillance for 12 months. Decrease transmission through extensive MDRO education with focus on patient education, monitor isolation, environmental and equipment practice compliance. Goal: < 0.15 infections\/1000 patient days.<\/p>\n
4. Nosocomial transmission of C. Diff infection surveillance for 12 months. Reduction in transmission through environmental cleanliness, equipment cleanliness, and proper antibiotic utilization. Goal: < 0.25 infections\/1000 patient days.<\/p>\n
5. Surgical Site Infections: All clean, surgical procedures per NHSN followed by means of surgeon surveys, lab reports, referrals, unit rounds and coders (readmissions) utilizing the risk adjusted SSI database. Focus reviews of any noted clusters. Goal: < 0.75 infections\/100 cases.<\/p>\n
6. Surgical Care Infection Prevention: Facilitate committee to include implementing changes to processes to allow Nightingale Community Hospital to meet targets. Improve Evidence Based Score (EBS) compliance related to antibiotic administered within 1 hour, Beta blockers, and VTE prophylaxis. Goal: EBS >90% before the end of the fiscal year.<\/p>\n
7. Hand Hygiene Guidelines: Monitor compliance to the hand hygiene policy including use of artificial nails for direct caregivers by direct observations and increased usage of alcohol foam\/gel on units and in surgical services. Develop unit ownership and expand availability of products. Evaluate staff\u2019s preference of gel vs. foam and convert if gel preferred. Goal: > 90% compliance rate to hand hygiene through observations.<\/p>\n
8. Employee Health: Communicable disease surveillance to include but not limited to TB exposures and immunization compliance including influenza. Goal: \u201cZero\u201d PPD conversions from TB exposures.<\/p>\n
9. Employee Health: Influenza prevention program expansion with 2009\u20132010 – Essay Writing Service: Write My Essay by Top-Notch Writer goal of overall 90% immunization rate with each nursing unit reaching at least 75%.<\/p>\n
10. Employee Health: Decrease in blood and body fluid exposures through staff awareness and sharps safety compliance with review of safety devices focusing on medical staff exposures. Goal: < 1.2 exposures per 1000 patient days.<\/p>\n
11. Nonemployee Health Screening: Continued compliance with nonemployee (LIP, Allied Health Staff, clinical contract) staff for all health requirements with a focus on contract staff. Goal: >95% of staff compliant with employee health requirements prior to beginning employment or contract.<\/p>\n
12. CSR PI: Continued monitoring of sterilization documentation and flash utilization in CSR. Goal: Flash rates of < 80 loads\/1000 cases.<\/p>\n
13. National Patient Safety Goals Compliance: Fully implement and monitor compliance to the National Patient Safety Goals related to Infection Prevention.<\/p>\n
Information Management Abbreviation Policy.pdf
\nPatient Care Policy: Prohibited Abbreviations<\/p>\n
Policy<\/p>\n
The use of abbreviations and symbols in the medical record is discouraged to prevent errors.<\/p>\n
Prohibited abbreviations and\/or symbols can be associated with misinterpretation, resulting in medical errors and patient harm. If the intended meaning of an abbreviation or symbol in the context of a specific order is not clear, the ordering practitioner must be contacted for clarification.<\/p>\n
See Addendum 1 for a list of medical staff-approved prohibited abbreviations.<\/p>\n
Page 2<\/p>\n
Addendum 1<\/p>\n
Information Management Admission Orders A.pdf
\nNIGHTINGALE COMMUNITY HOSPITAL ADMISSION ORDERS<\/p>\n
Authorization is hereby given to dispense the generic equivalent unless otherwise indicated by the physician.<\/p>\n
1.<\/p>\n
Admit to service of Dr. ________________________ \uf063 Inpatient \uf063 Observation \uf063 Med\/Surg \uf063 Tele \uf063 ICU<\/p>\n
Allergies ___________________________________________________________________________________<\/p>\n
\uf063 I need help writing my essay – research paper notify primary care physician of admission (courtesy call)<\/p>\n
2. Consults\/Education<\/p>\n
\uf063 Cardiologist ______________________Reason____________________ \uf063 A.M. \uf063 Routine \uf063 STAT \uf063 Hospitalist Reason____________________ \uf063 A.M. \uf063 Routine \uf063 STAT \uf063 Cardiac Rehab \uf063 Nutrition Consult \uf052 Smoking Cessation Education (if applicable): CMS criteria<\/p>\n
\uf052 Case Management Consult<\/p>\n
\uf063 Other consults ________________________________ Reason___________________________________<\/p>\n
3. Diet<\/p>\n
\uf063 NPO \uf063 NPO except medications \uf063 Low fat \uf063 2 grams NA (Sodium) \uf063 Other (Specify) __________________________________________________________________________ \uf063 p.o. fluid restriction of: ________________ ml\/day<\/p>\n
4. Activity<\/p>\n
\uf063 Bed rest with HOB elevated \uf063 Other:________________________________________________________ \uf063 Activity as tolerated<\/p>\n
5. Vital signs with pulse oximetry<\/p>\n
\uf063 Per unit standard \uf063 Every 4 hours and as needed \u25a1 Cardiac monitor 6. Medications<\/p>\n
\uf063 Tylenol 650 mg p.o. \/ pr q 4 hours prn mild pain. Do not exceed 4 grams Acetaminophen in 24 hours<\/p>\n
\uf063 Hydrocodone-Ace homework tutors – APAP (Norco 5\/325 mg) 1-2 tablets p.o. q 6 hours prn moderate pain.<\/p>\n
\uf063 Morphine 2 mg \u2013 4 mg IV q _________ hours prn moderate pain.<\/p>\n
\uf063 Ambien 5mg \u2013 10 mg p.o. qhs prn sleep.<\/p>\n
\uf063 Phenergan 6.25 mg \u2013 12.5 mg IV or 12.5 mg p.o. q 4 hours prn nausea.<\/p>\n
\uf063 Laxative of Choice \uf063 Antacid of Choice<\/p>\n
7. \uf052 Weigh immediately on admission and every a.m.<\/p>\n
8. \uf052 Intake & Output every shift<\/p>\n
9. Labs\/Tests \uf063 May travel off monitor<\/p>\n
\uf063 EKG on admission (if not done in Emergency Department) \uf063 CBC \uf063 Basic metabolic panel \uf063 Magnesium \uf063 Phosphate \uf063 Calcium \uf063 Urinalysis \uf063 Other____________________________________________________________________<\/p>\n
V.O. __________________________________ RB by\/______________ Signature ________________________________ M.D. Date ________ Time _______ (All verbal orders must be authenticated within 48 hours)<\/p>\n
Patient Identification<\/p>\n
ADMISSION ORDERS<\/p>\n
PHYSICIAN ORDER FORM<\/p>\n
Patient A<\/p>\n
Information Management NPSG Data.pdf
\n1<\/p>\n
Number of times it was reported that a labeling error occurred<\/p>\n
22<\/p>\n
3<\/p>\n
Medication Management Medication Administration Policy.pdf
\nPatient Care Policy: Medication Administration<\/p>\n
Policy<\/p>\n
Medications are to be administered upon order of a qualified physician, podiatrist, dentist, or other practitioner duly licensed or authorized to prescribe by the state and who has been approved as a member of the medical or allied health staff of Nightingale Community Hospital (NCH). All orders for medication shall be written into the medical record of the patient.<\/p>\n
Authority to administer medications is based on formalized education and training, past work experience, in- house training and annual performance appraisals.<\/p>\n
Medication Administration at NCH is limited to professional healthcare practitioners listed below within the specifications of established hospital policies and procedures and approved job descriptions:<\/p>\n
Physicians<\/p>\n
Podiatrists<\/p>\n
Physician Assistants<\/p>\n
Licensed Nurse Practitioners<\/p>\n
Registered Nurses<\/p>\n
Licensed Practical Nurse<\/p>\n
Nursing students (with instructor supervision)<\/p>\n
CRN Anesthetists<\/p>\n
EEG Technicians<\/p>\n
Physical Therapists<\/p>\n
Respiratory Therapists<\/p>\n
Radiology Technicians<\/p>\n
Nuclear Technologists<\/p>\n
CT Scan Technicians<\/p>\n
MRI Technicians<\/p>\n
Ultrasound Technicians<\/p>\n
Registered nurses (RNs) and licensed practical nurses (LPNSs) may administer all parenteral, oral, rectal, and topical medication including blood and blood products if not specifically excluded elsewhere by medical staff by- laws or hospital policy and procedure.<\/p>\n
The following policies will govern administration of medication in this institution:<\/p>\n
The individual administering the medication will verify the medication selected for administration is the correct medication based on the medication order and the medication product label.<\/p>\n
The individual administering a medication will be aware of the following information concerning each medication before administration:<\/p>\n
o Therapeutic action<\/p>\n
Page 2<\/p>\n
o Uptoward actions or side effects<\/p>\n
o Antidote (if applicable) and its location<\/p>\n
o Route and frequency of administration<\/p>\n
o Appropriate timing of medication administration<\/p>\n
o Normal dosage and maximum safe dosage<\/p>\n
o Signs of medication deterioration<\/p>\n
o Precautions<\/p>\n
o Any contraindications that would preclude the administration of the medication<\/p>\n
o The expiration date of the medication to ensure it has not been exceeded<\/p>\n
The individual administering a new medication will advise the patient, or if appropriate the patient’s family, about the purpose of the medication and what to expect from the medication.<\/p>\n
The individual administering a medication will discuss any unresolved, significant concerns about the medication with the patient’s physician, prescriber (if different from the physician), and\/or relevant staff involved with the patient’s care, treatment, and services.<\/p>\n
Questions regarding medication compatibility will be referred to the pharmacist or research in available compatibility references.<\/p>\n
There must be a specific order written by the physician before medication can be left at the patient’s bedside. Drugs for PRN use at the bedside consist primarily of sublingual antianginal products and antacids. See “Patient Self-Administration of Medications and Bedside Medications” in the Patient Care Policy for procedures.<\/p>\n
Dose preparation will be performed in well-lit areas.<\/p>\n
Positive identification of the patient will be ascertained by the individual administering the medication by reading the identification wristband and following the organizational Patient Identification for Clinical Care and Treatment policy which requires the use of two (2) patient identifiers prior to administration of all medications.<\/p>\n
All medications, including mixed solutions will be observed to assure that the medication is stable and that there are no signs of precipitation, discoloration, or particulate matter prior to patient administration.<\/p>\n
Medications will be prepared immediately prior to administration, particularly medications prepared for parenteral administration, according to unit dose protocol. To the maximum extent possible, drugs are to be administered by the person preparing the dose.<\/p>\n
The nurse administering the medication will stay with the patient until the medication is taken. If a medication has been opened and is refused by a patient it is to be destroyed. This also applies to medications held because of nurse discretion. (If a medication is held or refused, a notation is made on the patient’s medical record.) Wasted control drugs will be witnessed and cosigned.<\/p>\n
The nurse assigned to a patient coming from surgery will review PACU and anesthesia records of patients returning from surgery to ascertain doses and times of medications administered in surgery and PACU. This also applies to patients transported from the emergency department.<\/p>\n
Medication orders that \u2026<\/p>\n","protected":false},"excerpt":{"rendered":"
Communication NPSG Data.pdf National Patient Safety Goal Data: Communication NPSG 2: Improving Effectiveness of Communication\u2014 Critical Results 63 58 62 75 68 56 57 82 77 78 82 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pagelayer_contact_templates":[],"_pagelayer_content":"","footnotes":""},"categories":[1830],"tags":[1832,1232,1780,1089],"class_list":["post-3983","post","type-post","status-publish","format-standard","hentry","category-nursing-homework","tag-healthcare-dissertations","tag-medical-research-papers","tag-nursing-case-study","tag-healthcare-essays"],"_links":{"self":[{"href":"https:\/\/www.homeworkacetutors.com\/acemyhomework\/wp-json\/wp\/v2\/posts\/3983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.homeworkacetutors.com\/acemyhomework\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.homeworkacetutors.com\/acemyhomework\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.homeworkacetutors.com\/acemyhomework\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.homeworkacetutors.com\/acemyhomework\/wp-json\/wp\/v2\/comments?post=3983"}],"version-history":[{"count":0,"href":"https:\/\/www.homeworkacetutors.com\/acemyhomework\/wp-json\/wp\/v2\/posts\/3983\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.homeworkacetutors.com\/acemyhomework\/wp-json\/wp\/v2\/media?parent=3983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.homeworkacetutors.com\/acemyhomework\/wp-json\/wp\/v2\/categories?post=3983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.homeworkacetutors.com\/acemyhomework\/wp-json\/wp\/v2\/tags?post=3983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}